NeoStem Obtains Exclusive Worldwide License for Innovative Stem Cell Technology and Applications to Heal Chronic Wounds
NeoStem, Inc. , which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need, announced today it has signed an agreement to license the exclusive worldwide rights to an innovative product and procedure using autologous bone marrow-derived stem cells to promote the healing of chronic wounds.
[Read the full article here]Related News:
NeoStem Obtains Exclusive Worldwide License to Innovative Stem Cell … – MSN MoneyCentral
NeoStem obtains exclusive license to innovative stem cell procedure treating musculoskeletal diseases
NeoStem gets worldwide licence to stem cell tech for skin therapies (PharmaBiz)